Internal Medicine NewsLupus nephritis: Hopes, questions arise for baricitinibJune 1, 2023RheumatologyNephrology
Internal Medicine NewsILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDsJune 1, 2023RheumatologyPulmonology
Internal Medicine NewsMultiple successive biologic to biosimilar switches deemed safe and effectiveMay 31, 2023GastroenterologyRheumatologyMixed Topics
Internal Medicine NewsSevere hydroxychloroquine nonadherence linked to worse SLE outcomesMay 25, 2023Rheumatology
Internal Medicine NewsAxSpA remission on TNFi seen in half of patients with comorbid IBDMay 25, 2023GastroenterologyRheumatology
Internal Medicine NewsFDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023Rare DiseasesDermatologyGastroenterologyRheumatology
Internal Medicine NewsLupus landmark study aims for personalized medicine goalsMay 24, 2023Rheumatology
Internal Medicine NewsFDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023DermatologyGastroenterologyRheumatologyRare Diseases
Internal Medicine NewsResearchers make headway in understanding axSpA diagnostic delayMay 22, 2023Rheumatology
Internal Medicine NewsBiomarkers for measuring lupus nephritis treatment response gain groundMay 19, 2023NephrologyRheumatology
Internal Medicine NewsMACE, VTE rates compared between TNF and JAK inhibitors for AxSpA and PsAMay 19, 2023Rheumatology
Internal Medicine NewsInvestigational drug peresolimab shows efficacy in patients with RAMay 17, 2023Rheumatology
Internal Medicine NewsRheumatoid arthritis linked to increased Parkinson’s riskMay 11, 2023RheumatologyNeurology
Internal Medicine NewsCutaneous vasculitis curtails quality of lifeMay 11, 2023Rare DiseasesRheumatologyDermatology